Univariate predictors of outcome for 203 patients
Characteristic . | Overall survival log-rank P value . | Freedom from progression log-rank P value . |
---|---|---|
Sex | .21 | .56 |
Serum M spike | .9 | .82 |
Urine total protein | .1 | .25 |
β2-microglobulin | .016 | .14 |
Lactate dehydrogenase | .48 | .6 |
C-reactive protein | .07 | .64 |
Bone disease | .11 | .49 |
% plasma cells in bone marrow | .001 | .001 |
Plasma cell labeling index | .001 | .001 |
Creatinine | .42 | .88 |
Age | .77 | .77 |
Δ13q | .004 | .017 |
−17p13.1 (TP53) | .04 | .003 |
t(11;14)(q13;q32) | .7 | .35 |
t(4;14)(p16.3;q32) | .001 | .001 |
Status at stem cell transplantation | .001 | .001 |
Characteristic . | Overall survival log-rank P value . | Freedom from progression log-rank P value . |
---|---|---|
Sex | .21 | .56 |
Serum M spike | .9 | .82 |
Urine total protein | .1 | .25 |
β2-microglobulin | .016 | .14 |
Lactate dehydrogenase | .48 | .6 |
C-reactive protein | .07 | .64 |
Bone disease | .11 | .49 |
% plasma cells in bone marrow | .001 | .001 |
Plasma cell labeling index | .001 | .001 |
Creatinine | .42 | .88 |
Age | .77 | .77 |
Δ13q | .004 | .017 |
−17p13.1 (TP53) | .04 | .003 |
t(11;14)(q13;q32) | .7 | .35 |
t(4;14)(p16.3;q32) | .001 | .001 |
Status at stem cell transplantation | .001 | .001 |